AI Image
Macleods Pharma USA, Inc. Just Recalled 3,700 Bottles of Blood Pressure Meds
Prevention • • health
Key Points:
- Nearly 4,000 bottles of blood pressure medication containing olmesartan medoxomil, amlodipine, and hydrochlorothiazide have been voluntarily recalled nationwide by Macleods Pharma USA, Inc. due to failure to meet dissolution specifications, potentially rendering the drugs ineffective.
- The FDA classified the recall as Class II on October 26, indicating that use of the affected medication may cause temporary or medically reversible adverse health effects.
- The recall includes specific 30-count and 90-count bottles with lot numbers 12251163A and 12251163B, both expiring on May 31, 2027; patients are advised to check their medication labels carefully.
- Patients who possess the recalled products should consult the FDA’s enforcement report for more details and contact their healthcare provider for guidance on managing their blood pressure treatment.
